CNE100000GF1
CNE100000GF1
CHASE SUN PHARM.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2024 | 2023 | Change % |
|---|---|---|---|
| Total Revenue | 5.782.766.929 | 6.108.854.649 | 5.3% |
| Cost of Revenue | 2.731.900.618 | 2.803.386.935 | 2.5% |
| Gross Profit | 3.050.866.311 | 3.305.467.715 | 7.7% |
| 2.789.632.332 | 2.667.037.332 | 4.6% | |
| Operating Income | 261.233.979 | 638.430.383 | 59.1% |
| Pretax Income | 53.984.535 | 606.823.073 | 91.1% |
| Net Income Common Stockholders | 21.467.323 | 506.631.426 | 95.8% |
| -- | -- | -- | |
| -- | -- | -- |